Hufnagel et al. reported that anemia was observed in 21.7% of gynecologic cancers with a median Hb of 9.8 g/dL; however, only 36% of patients with anemia underwent evaluation for iron deficiency anemia (IDA) or anemia of chronic disease [5]. Here, GSTM1 is linked to anemia (phenotype).